Skip to main content
PLUR
NASDAQ Life Sciences

EIB Defers Enforcement on $27.4M Loan, Engages in Resolution Talks Until July 3

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$2.41
Mkt Cap
$26.003M
52W Low
$2.22
52W High
$5.96
52W Position info
8.6% above low
Off High info
60% below high
Rel. Volume info
5.2× avg
Market data snapshot near publication time

PLUR is trading near its 52-week low of $2.22 (8.6% above the low) on elevated volume (5.2× avg).

Summary

Pluri Inc. received a temporary deferral from the European Investment Bank on its $27.4 million loan, with discussions for a resolution ongoing until July 3, 2026, providing a short-term reprieve from immediate default.


Key Events · Financing and Capital Events · PLUR

  • EIB Loan Maturity Update

    The European Investment Bank (EIB) has confirmed it will defer enforcement actions on Pluri's €20 million loan (approximately $27.4 million including interest), which was due on June 1, 2026.

  • Constructive Discussions Ongoing

    The EIB and Pluri Inc. are engaged in constructive discussions to explore a mutually agreed resolution, with negotiations expected to conclude by July 3, 2026.

  • Temporary Reprieve from Default

    This agreement provides Pluri Inc., which is facing an acute liquidity crisis, a temporary stay from immediate default on a significant debt obligation.


Analysis · PLUR · Life Sciences

Pluri Inc., facing an acute liquidity crisis and a significant EIB loan maturity, has secured a temporary reprieve. The EIB has agreed to defer enforcement actions and engage in constructive discussions until July 3, 2026, to find a mutually acceptable resolution. This buys the company critical time to address its financial challenges and avoid immediate default on a loan that is larger than its current market capitalization.

At the time of this filing, PLUR was trading at $2.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $26M. The 52-week trading range was $2.22 to $5.96. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLUR - Latest Insights

PLUR
Jul 14, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.68
Real-time Price: $1.80 info
Change: +$0.120 (+7%) info
Market Cap: $19.421M info
PLUR
Jul 13, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.63
Real-time Price: $1.80 info
Change: +$0.170 (+10%) info
Market Cap: $19.421M info
PLUR
Jul 01, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.09
Real-time Price: $1.80 info
Change: -$0.290 (-14%) info
Market Cap: $19.421M info
PLUR
Jun 22, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.02
Real-time Price: $1.80 info
Change: -$0.220 (-11%) info
Market Cap: $19.421M info
PLUR
Jun 22, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.02
Real-time Price: $1.80 info
Change: -$0.220 (-11%) info
Market Cap: $19.421M info
PLUR
Jun 02, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.41
Real-time Price: $1.80 info
Change: -$0.610 (-25%) info
Market Cap: $19.421M info
PLUR
Jun 01, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.41
Real-time Price: $1.80 info
Change: -$0.610 (-25%) info
Market Cap: $19.421M info
PLUR
May 14, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.40
Real-time Price: $1.80 info
Change: -$1.60 (-47%) info
Market Cap: $19.421M info
PLUR
May 01, 2026, 7:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $3.35
Real-time Price: $1.80 info
Change: -$1.55 (-46%) info
Market Cap: $19.421M info
PLUR
Mar 27, 2026, 6:33 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.22
Real-time Price: $1.80 info
Change: -$1.42 (-44%) info
Market Cap: $19.421M info